Stockscreener 앱 받기
1.79
2.87%
0.05
시간 외 거래:
1.79
Nkarta Inc 주식(NKTX)의 최신 뉴스
Quince Therapeutics Relaunches as IRulya Therapeutics with a Focus on the Clinical Development of LAM-001, Targeting a Key Pathway in Pulmonary Disease - The Manila Times
Nkarta (NKTX) Edges Higher to $2.58 as Traders Watch $2.45 Support and $2.71 ResistanceATR Trailing Stop - siam.in
Lantern Pharma Inc. (LTRN) stock price, news, quote and history - Yahoo Finance Australia
Lantern Pharma Inc. (LTRN) stock price, news, quote and history - Yahoo Finance UK
Stifel reiterates Buy rating on Nkarta stock, cites trial progress By Investing.com - Investing.com Nigeria
Stifel reiterates Buy rating on Nkarta stock, cites trial progress - Investing.com
Stifel reiterates Buy rating on Nkarta stock, cites trial progress By Investing.com - Investing.com UK
Nkarta to Participate in September Investor Conferences - Investing News Network
Two Nkarta investor talks will be webcast in September - Stock Titan
Nkarta Insiders Got A Good Deal Selling At US$2.10 - simplywall.st
Nkarta to Present Initial Autoimmune Clinical Data for - GlobeNewswire
Nkarta’s autoimmune cell therapy will get two talks and a poster - Stock Titan
Nkarta: 'Hold' NKX019 Discontinuation For R/R NHL And Pivot To Autoimmune Disorders - Seeking Alpha
NKARTA STOCK : BIG PRICE RECOVERY | NKTX STOCK Rinku Singh (yKkQAHM32g) - Mshale
Nkarta Inc (NASDAQ: NKTX) Stock Price, News & Analysis - Kalkine
Dare Bioscience Prices $6.0 Million Registered Direct Offering - minichart.com.sg
Monaco Asset Management SAM Makes New Investment in Nkarta, Inc. $NKTX - MarketBeat
Analysts Are Bullish on Top Healthcare Stocks: Idexx Laboratories (IDXX), Nkarta (NKTX) - The Globe and Mail
Nkarta (NASDAQ:NKTX) Stock Rating Lowered by Wall Street Zen - MarketBeat
Stifel cuts Nkarta stock price target on updated model By Investing.com - Investing.com Australia
Stifel cuts Nkarta stock price target on updated model By Investing.com - Investing.com Canada
Stifel cuts Nkarta stock price target on updated model By Investing.com - Investing.com Nigeria
Stifel cuts Nkarta stock price target on updated model - Investing.com
Stifel cuts Nkarta stock price target on updated model By Investing.com - Investing.com India
Stifel cuts Nkarta stock price target on updated model By Investing.com - Investing.com UK
Stifel cuts Nkarta stock price target on updated model - Investing.com
Stifel Nicolaus Has Lowered Expectations for Nkarta (NASDAQ:NKTX) Stock Price - MarketBeat
Nkarta Inc (NASDAQ: NKTX) Stock Price, News & Analysis - kalkine.ca
Nkarta Inc. (NKTX) Edges Higher as Biotech Stock Holds Key Support ZoneEase of Movement - vinanet.vn
Nkarta Inc. (NKTX) Edges Higher as Biotech Stock Holds Key Support ZoneHigh Conviction Picks - dars.gov.et
Equities Analysts Set Expectations for Nkarta Q3 Earnings - MarketBeat
Analysts Offer Insights on Healthcare Companies: Nkarta (NKTX) and Rocket Pharmaceuticals (RCKT) - The Globe and Mail
NKARTA STOCK : BIG PRICE RECOVERY | NKTX STOCK Rinku Singh (yKkQAHM32g) - Mshale
Nkarta, Inc. Stock 12‑Month Price Target Cut to $11, Implies 347% Upside - TradingView
H.C. Wainwright cuts Nkarta stock price target on trial progress - Investing.com
H.C. Wainwright cuts Nkarta stock price target on trial progress By Investing.com - Investing.com Australia
H.C. Wainwright cuts Nkarta stock price target on trial progress By Investing.com - Investing.com UK
H.C. Wainwright cuts Nkarta stock price target on trial progress - Investing.com
NKARTA, INC. : H.C. WAINWRIGHT CUTS TARGET PRICE TO $14 FROM $16 - Bitget
NKTX Q2 2026 Earnings: Wider Loss of $0.54 Per Share Misses Estimates as Clinical-Stage Costs EscalateFinancial Data - vinanet.vn
Nkarta, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Nkarta (NASDAQ:NKTX) Posts Quarterly Earnings Results, Misses Estimates By $0.18 EPS - MarketBeat
Nkarta Q2 EPS of $(0.54) misses $(0.38) analyst estimate - scanx.trade
Nkarta Reports Continued Enrollment in Ntrust Autoimmune Trials and $243.2 Million Cash Position, Reaffirms Runway Into 2029 - Quiver Quantitative
Nkarta Reports Second Quarter 2026 Financial Results and Corporate Highlights - GlobeNewswire
Nkarta Reports Second Quarter 2026 Financial Results and Corporate Highlights - Yahoo Finance
Nkarta, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Nkarta, Inc. (NASDAQ:NKTX) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
NKTX Q1 2026 Earnings: Narrower-Than-Expected Loss Supports 5.24% Share GainROIC Trend Report - vinanet.vn
Nkarta, Inc. expected to post a loss of 38 cents a shareEarnings Preview - TradingView
3.09%
0.72%
자본화:
|
볼륨(24시간):